O

    Oscar Health Inc (OSCR)

    Official site

    HEALTHCARE • HEALTHCARE PLANS • NYSE

    $29.94
    -0.53 (-1.74%)

    Market Cap: $9.25B

    Last updated: Sep 01, 2026 at 5:00 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    48%(11/23)
    Avg Surprise
    -1.09%
    Streak
    2 Q

    Upcoming Estimates

    Period ending Sep 30, 2026
    EPS Consensus$-0.25
    Range$-0.40 - $0.05
    9 analysts
    EPS Revisions
    1
    0
    7d
    2
    3
    30d
    EPS Estimate Drift
    90d ago$-0.19+21.3%
    60d ago$-0.19+22.6%
    30d ago$-0.20+17.1%
    7d ago$-0.18+26.4%
    Current$-0.25
    Revenue Consensus
    $4.7B
    Range$4.5B - $4.9B
    9 analysts
    Period ending Dec 31, 2026
    EPS Consensus$0.52
    Range$0.15 - $0.79
    8 analysts
    Revenue Consensus
    $4.3B
    Range$4.0B - $4.5B
    9 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$0.52---
    Sep 26EST
    		-$-0.25---
    Jun 26
    Reported Aug 6
    		$1.10$0.43+155.81%Beat+223.6%
    Mar 26
    Reported May 6
    		$2.07$1.10+88.18%Beat+125.0%
    Dec 25
    Reported Feb 10
    		$-1.24$-0.92-34.78%Miss-100.0%
    Sep 25
    Reported Nov 6
    		$-0.53$-0.58+8.62%Beat-140.9%
    Jun 25
    Reported Aug 6
    		$-0.89$-0.84-5.95%Miss-545.0%
    Mar 25
    Reported May 7
    		$0.92$0.81+13.58%Beat+48.4%
    Dec 24
    Reported Feb 4
    		$-0.62$-0.58-6.90%Miss+6.1%
    Sep 24
    Reported Nov 7
    		$-0.22$-0.18-22.22%Miss+24.1%
    Jun 24
    Reported Aug 7
    		$0.20$0.16+25.00%Beat+385.7%
    Mar 24
    Reported May 7
    		$0.62$0.27+129.63%Beat+444.4%
    Dec 23
    Reported Feb 7
    		$-0.66$-0.70+5.71%Beat+37.1%
    Sep 23
    Reported Nov 7
    		$-0.29$-0.47+38.30%Beat+68.1%
    Jun 23
    Reported Aug 8
    		$-0.07N/A+56.25%Beat+86.8%
    Mar 23
    Reported May 9
    		$-0.18$-0.09-100.00%Miss+50.0%
    Dec 22
    Reported Feb 9
    		$-1.05$-1.19+11.76%Beat-10.5%
    Sep 22
    Reported Nov 8
    		$-0.91$-0.69-31.88%Miss+10.8%
    Jun 22
    Reported Aug 11
    		$-0.53$-0.35-51.43%Miss-51.4%
    Mar 22
    Reported May 10
    		$-0.36$-0.12-200.00%Miss+52.0%
    Dec 21
    Reported Feb 10
    		$-0.95$-0.73-30.14%Miss+22.1%
    Sep 21
    Reported Nov 10
    		$-1.02$-0.65-56.92%Miss-
    Jun 21
    Reported Aug 12
    		$-0.35$-0.47+25.53%Beat-
    Mar 21
    Reported May 13
    		$-0.75$-0.54-38.89%Miss-
    Dec 20
    Reported Mar 4
    		$-1.22$-1.17-4.27%Miss-

    Key Metrics

    Valuation
    P/E Ratio21.39EV/EBITDAN/A
    Price/FCF2.07xFCF Yield48.41%
    Profitability
    Profit Margin3.60%Operating Margin7.96%
    ROE34.30%ROIC22.78%
    Financial Health
    Debt/Equity0.21xInterest Coverage38.21x
    Current Ratio1.08xQuick Ratio1.08x
    Trading Statistics
    Beta2.38Avg Volume5.82M
    52-Week High$33.5552-Week Low$10.69

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$31.16
    SMA 20$30.34
    SMA 50$30.24
    SMA 200$20.15
    EMA 10$30.72
    EMA 20$30.59
    EMA 50$29.29
    EMA 200$22.69

    MACD

    Line: 0.29Signal: 0.45Hist: -0.16

    ADX

    ADX: 19.2+DI: 21.9-DI: 18.9

    Aroon & PSAR

    Aroon Up80.0
    Aroon Down36.0
    PSAR$28.43

    Bollinger Bands

    Upper Band$33.72
    Lower Band$26.97
    %B Position2221%(Upper)
    Band Width0.44

    RSI (14-Day)

    Neutral
    47.8

    Momentum Oscillators

    Stoch %K45.1
    Stoch %D54.6
    Williams %R-62.9
    ROC (10d)-5.1%
    Momentum-1.61
    CCI (20d)-17.0
    MFI (14d)53.4

    Volatility Measures

    ATR (14d)$1.79(6.0%)
    StdDev (20d)1.69
    Hist Vol65.5%(High)

    Volume Flow

    VWAP$29.99
    OBV-54.9M
    AD Line-99.4M
    CMF (20d)0.009

    Volume Metrics

    Avg Vol (20d)5.9M
    Vol Ratio0.6x
    VWMA (20d)$29.84

    Pivot Points

    R3$33.84
    R2$32.68
    R1$31.57
    Pivot Point$30.41
    S1$29.30
    S2$28.14
    S3$27.03

    Advanced Oscillators

    TSI4.77
    Ultimate Osc45.0
    KST32.87

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$4.88B$4.65B$2.81B$2.99B$2.86B$3.05B$2.39B$2.42B$2.22B$2.14B$1.43B$1.44B
    Cost of Revenue$3.79B$3.23B$-7,398,954,000$2.59B$2.55B$2.26B$-3,263,496,000$0$1.71B$1.55B$-2,345,193,000$1.16B
    Gross Profit$1.09B$1.42B$10.20B$399.65M$310.97M$786.61M$5.66B$2.42B$510.62M$587.53M$3.78B$276.80M
    Operating Expenses$697.14M$713.25M$10.54B$528.90M$541.46M$489.49M$5.80B$2.47B$442.81M$401.97M$3.92B$335.04M
    R&D$0$0$0$0$0$0$0$0$0$0$0$0
    SG&A$691.08M$706.23M$511.03M$521.59M$534.49M$482.76M$465.82M$460.38M$435.21M$394.16M$364.15M$325.85M
    Operating Income$388.63M$704.09M$-333,747,000$-129,250,000$-230,483,000$297.12M$-147,731,000$-48,374,000$67.81M$185.56M$-145,477,000$-58,244,000
    Interest Income$0$0$0$0$0$0$0$0$0$0$0$0
    Interest Expense$4.71M$5.38M$-1,097,000$6.86M$5.85M$5.99M$6.03M$5.82M$5.99M$5.90M$6.22M$6.13M
    Income Before Tax$383.01M$698.77M$-352,681,000$-139,291,000$-233,536,000$288.21M$-153,689,000$-52,312,000$60.95M$178.48M$-150,644,000$-64,788,000
    Income Tax Expense$21.18M$19.75M$-247,000$-1,807,000$-5,045,000$12.71M$-404,000$2.08M$4.64M$996,000$-806,000$915,000
    Net Income$361.83M$679.02M$-352,434,000$-137,484,000$-228,491,000$275.51M$-153,285,000$-54,388,000$56.31M$177.48M$-149,838,000$-65,703,000
    EBITDA$386.69M$705.11M$-351,769,000$-132,136,000$-228,518,000$293.46M$-146,156,000$-45,540,000$68.74M$186.16M$-143,008,000$-56,854,000
    EBIT$387.72M$704.16M$-353,778,000$-132,434,000$-227,689,000$294.20M$-147,663,000$-46,497,000$66.94M$184.38M$-144,427,000$-58,658,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about OSCR

    News

    Mario Schlosser Sells 600,000 Shares of Oscar Health (NYSE:OSCR) Stock

    Oscar Health director Mario Schlosser sold 600,000 shares of the company's stock for $18.2 million, reducing his direct ownership by over 55%. This sale occurred while OSCR stock is trading near its 52-week high, despite analysts maintaining a "Hold" rating with a lower average price target. The company recently reported strong quarterly earnings and revenue, significantly exceeding consensus estimates.

    MarketBeat•8/31/26•
    Somewhat-Bearish

    Mario Schlosser Sells 150,000 Shares of Oscar Health (NYSE:OSCR) Stock

    Oscar Health director Mario Schlosser sold 150,000 shares of OSCR stock for $4.62 million, reducing his holdings by 23.78%. This sale is part of a series of substantial insider sales by Schlosser in recent months. Despite these insider sales, Oscar Health reported strong quarterly results with $1.10 EPS and $4.88 billion in revenue, and analysts maintain a "Hold" rating with an average price target of $26.22.

    MarketBeat•8/31/26•
    Somewhat-Bearish

    Oscar Health Inc - Ordinary Shares - Class A (OSCR) News, Articles, Events & Latest Updates

    This article compiles recent news and updates for Oscar Health Inc (OSCR), highlighting its strong momentum and "Strong Buy" ratings from Zacks for growth investors. It also includes news about Oscar Health's CEO exploring partnerships for new drug marketplaces and its Q2 2026 earnings call transcript. Additionally, there are unrelated news snippets about the sale of the Los Angeles Lakers.

    Stocktwits•8/24/26•
    Bullish

    Oscar Health CFO Blackley sells $595,125 in shares By Investing.com

    Richard Scott Blackley, CFO of Oscar Health Inc. (NYSE:OSCR), sold 18,750 shares of Class A Common Stock for a total of $595,125 on August 18, 2026. This transaction occurred while Oscar Health shares are near their 52-week high, despite InvestingPro analysis suggesting the stock is overvalued. The sale follows a strong second quarter where Oscar Health exceeded revenue and earnings expectations.

    Investing.com Nigeria•8/21/26•
    Somewhat-Bearish

    Oscar Health CFO Blackley sells $595,125 in shares By Investing.com

    Oscar Health CFO Richard Scott Blackley sold 18,750 shares of the company's Class A Common Stock for a total of $595,125 on August 18, 2026. This sale occurred as Oscar Health shares traded near their 52-week high, following strong financial results in Q2 2026 where the company surpassed analyst expectations for earnings and revenue. Despite positive performance, the stock saw a premarket decline, suggesting investor focus on future outlooks.

    Investing.com South Africa•8/21/26•
    Neutral

    Frequently Asked Questions About OSCR

    Does OSCR pay dividends?
    Oscar Health Inc (OSCR) does not currently pay a regular dividend.
    What is OSCR's P/E ratio?
    Oscar Health Inc has a price-to-earnings (P/E) ratio of 21.39.
    What is OSCR's market cap?
    Oscar Health Inc (OSCR) has a market capitalization of $9.25B with a current stock price of $29.94.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In